Theriva Biologics Inc. (TOVX) is a biotechnology company listed on NYSE MKT.
Latest reported TOVX revenue for 2026-06-30 was $300.0K. Net income was -$5.3M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. TOVX currently screens at market cap $12.4M.
Use this TOVX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the TOVX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the TOVX SEC filings page. Lician reads the product cache first so this HTML stays unique to Theriva Biologics Inc. even when a live quote feed is slow.
Latest cached year on this hub. Full TOVX income, balance, and cash tables.